• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

303-07-1 (2,6-Dihydroxybenzoic acid)

1

Identification

2,6-Dihydroxybenzoic acid 2,6-Dihydroxybenzoic acid
Name 2,6-Dihydroxybenzoic acid
Formula C7H6O4
MW 154.12
CAS No. 303-07-1
EINECS 206-134-8
Smiles OC1=CC=CC(O)=C1C(O)=O
Synonyms 2,6-Resorcylic acid; gamma-Resorcylic acid; 2,6-dihydroxybenzoic acid
InChI InChI=1S/C7H6O4/c8-4-2-1-3-5(9)6(4)7(10)11/h1-3,8-9H,(H,10,11)
2

Introduction

2,6-Dihydroxybenzoic acid is a secondary metabolite of salicylic acid which has been hydrolyzed by liver enzymes during phase I metabolism.

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB000032310

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways
Target
Research Area
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
2,6-Dihydroxybenzoic acid - No Development Reported
7

Safety Data of 2,6-Dihydroxybenzoic acid

´╗┐Hazard Symbols : Xi
´╗┐Risk Statements : R36/37/38
Safety Statements : S26;S36
HS Code : 29182990
RTECS : DG8578000
WGKGermany : 3
8

Spectral Information

9

Suppliers List

10

Related Products

Other Forms of 303-07-1

Name CAS No Formula MW

Recommended Compounds in

Name CAS No Formula MW

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

2,6-Dihydroxybenzoic acid

Tags: buy 303-07-1 IC50 | 303-07-1 price | 303-07-1 cost | 303-07-1 solubility | 303-07-1 purchase | 303-07-1 manufacturer | 303-07-1 research buy | 303-07-1 order | 303-07-1 MSDS | 303-07-1 chemical structure | 303-07-1 Storage condition | 303-07-1 molecular weight | 303-07-1 mw | 303-07-1 datasheet | 303-07-1 supplier | 303-07-1 cell line | 303-07-1 NMR | 303-07-1 MS | 303-07-1 IR | 303-07-1 solubility | 303-07-1 Safe information | 303-07-1 Qc and Spectral Information | 303-07-1 Clinical Information | 303-07-1 Clinical Trial | 303-07-1 Route of Synthesis | 303-07-1 storage condition | 303-07-1 diseases and conditions | 303-07-1 flash point | 303-07-1 boiling point | 303-07-1 melting point | 303-07-1 storage condition | 303-07-1 brand